Pfenex Company
Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2009
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership